Company intelligence / Profile preview

Serrado Capital

New York, New York, United Statescrunchbase.com ↗

Ownership: Private
Development stage: Other

Overview

Serrado Capital is a New York-based family office and venture capital investment firm founded in 2010. It focuses on investments in the healthcare sector, including life sciences and health technology companies. The firm has participated as an investor in notable biotech financings such as IO Biotech’s Series B round. It does not develop drugs or have its own clinical pipeline.

Industry: Investors

Partnerships

Participated as co-investor with other major VC firms and funds in syndicates for portfolio companies such as IO Biotech

Beyond the preview

Go deeper on Serrado Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serrado Capital.

Explore the full profile